GLP-2 TZ

Contents Tirzepatide Form / storage Lyophilized powder; store at −20 °C, protect from light Purity ≥98% — see lot COA CAS 2023788-19-2 Molecular formula C225H348N48O68 Molecular weight 4813.45 g/mol Sizes 10–60 mg Testing Identity (UV/Vis λmax), purity, assay (Beer-Lambert), heavy metals, microbial (TAMC/TYMC) COA Batch-specific — view on this page Research background Tirzepatide is a synthetic peptide built on a GIP-based backbone that engages both the GIP receptor and the GLP-1 receptor. Non-coded Aib residues at positions 2 and 13 and a C20 fatty-diacid acylation provide proteolytic stability and albumin binding for an extended half-life; the literature frequently describes it as an imbalanced/biased dual agonist. Research interest centers on how simultaneous GIP and GLP-1 receptor activation modulates insulin secretion, adipocyte signaling, and energy-balance pathways in preclinical systems, and on comparing co-agonism with single-receptor agonism. Research applications Probe for dual GIP/GLP-1 receptor signaling and biased-agonism studies Preclinical models of glucose and lipid metabolism Comparator in multi-receptor incretin pharmacology Quality & documentation Every lot is tested by an independent third-party laboratory before it enters the catalog.